Veterinary Medicines

FEBRIVAC 3-PLUS

Not authorised
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
  • Clostridium botulinum, type C, toxoid
  • Mink enteritis virus, Inactivated
Download as PDF

Product identification

Medicine name:
FEBRIVAC 3-PLUS
Active substance:
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
  • Clostridium botulinum, type C, toxoid
  • Mink enteritis virus, Inactivated
Target species:
  • Mink
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • Clostridium botulinum, type C, toxoid
    0.50
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, Inactivated
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Mink
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download